The CGMs currently on the market are invasive or minimally invasive. No noninvasive CGMs are currently on the market. The conventional wisdom is that noninvasive continuous glucose monitoring represents the true “Holy Grail” of glucose monitoring.
ECTE is the only noninvasive device coming on the market
One company in particular, Echo Therapeutics (ECTE – SB), is developing a noninvasive CGM system, which could redefine the market to the detriment of the minimally invasive systems offered by DexCom and Medtronic.